Copy Link Print Information

Nutlin-3a

(Synonyms: Rebemadlin)
74 Cited Publications
Kundenbewertung

Based on 74 publication(s) in Google Scholar

Nutlin-3a (Rebemadlin), an active enantiomer of Nutlin-3, is a potent murine double minute (MDM2) inhibitor (IC50=90 nM). Nutlin-3a inhibits MDM2-p53 interactions and stabilizes the p53 protein, and induces cell autophagy and apoptosis. Nutlin-3a has the potential for the study of TP53 wild-type ovarian carcinomas.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.13%
  • CAS. Nr.: 675576-98-4
  • Formel: C30H30Cl2N4O4
  • Molecular Weight:581.49
  • Speicherung:
    Powder   -20°C, 3 years ; In solvent   -80°C, 1 year , -20°C, 6 months
  • Nutlin-3a Chemical Structure
    Nutlin-3a Chemical Structure
  • Experimental Validation Results for Nutlin-3a
  • Experimental Validation Results for Nutlin-3a
  • Experimental Validation Results for Nutlin-3a
  • Experimental Validation Results for Nutlin-3a
  • Experimental Validation Results for Nutlin-3a
  • Experimental Validation Results for Nutlin-3a
  • Experimental Validation Results for Nutlin-3a
CAS. Nr.: 675576-98-4
Größe
Preis
Verfügbarkeit
Menge
Amount: USD 0.00
Please select quantity
or
or

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Nutlin-3a:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Finden Sie Ihren Händler vor Ort Your local distributor: Hycultec GmbHHycultec
  • Biologische Aktivität
  • Chemical Information
  • Lösungsmittel & Löslichkeit
  • Protokoll
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Nutlin-3a

More
Customer Validation & Images
WBCell Proliferation/Viability AssayRT-PCRIPIF
  • WB
  • Cell Proliferation/Viability Assay
  • RT-PCR
  • WB
  • WB
  • IF
  • IP
Keywords
100 mg

Angebot einholen Auf Lager

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Einloggen
Registrieren
Sign in to MedChemExpress
Neuen Account Registrieren

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Nutlin-3a Chemical Structure
    Nutlin-3a Chemical Structure
    1/16
  • 1/16

    Nutlin-3a purchased from MedChemExpress. Usage Cited in: Cancer Cell. 2024 May 13;42(5):850-868.e9. [Abstract]

    Customer Validation
     Immunoblotting of Eμ-Myc lymphoma (AF47A/560) and DHL (214DHL) cell lines pre-treated with QVD-O-Ph then S63845, venetoclax, or Nutlin-3a for indicated time points. HSP70 was used as a loading control.

  • 1/16

    Nutlin-3a purchased from MedChemExpress. Usage Cited in: Cancer Cell. 2024 May 13;42(5):850-868.e9. [Abstract]

    Customer Validation
     Cell viability assays of NTC and TP53 KO human B cell lymphoma cell lines. Cells were treated with the p53-activating drug Nutlin-3a for 24 h. Cell viability was measured by Annexin V/PI staining followed by flow cytometry. Error bars represent S.D. for three independent experiments. Student’s t-test; **=p<0.01, *=p<0.05.

  • 1/16

    Nutlin-3a purchased from MedChemExpress. Usage Cited in: Cancer Cell. 2024 May 13;42(5):850-868.e9. [Abstract]

    Customer Validation
     RTqPCR for the p53 target genes PUMA and P21 in parental DOHH2 and two independently derived Rho0 cell lines. Cells were pre-treated with the caspase inhibitor QVD-O-Ph (HY-12305), and then treated with 100 nM S63845 for 24 h or, as a comparator for potent p53 activation, treated with 10 µM of the MDM2 inhibitor Nutlin-3a (HY-10029) for 24 h. Ct values for each gene are normalized to the housekeeping gene HMBS, and fold change is shown relative to the DMSO-treated parental cell sample. Error bars represent S.E.M. for two independent experiments.

  • 1/16

    Nutlin-3a purchased from MedChemExpress. Usage Cited in: Cancer Cell. 2024 May 13;42(5):850-868.e9. [Abstract]

    Customer Validation
     Immunoblotting for p53 and PUMA in parental DOHH2 lymphoma cells and two independently derived Rho0 cell lines. Cells were pre-treated with QVD-O-Ph (HY-12305), and then treated with 100 nM S63845 or, as a control for potent p53 stabilization, treated with 10 µM Nutlin-3a (HY-10029) for 24 h. Blotting for HSP70 was used as a loading control. Representative blot shown from three independent experiments. Quantifications of p53 protein levels from three independent immunoblotting experiments are shown, relative to HSP70. Error bars represent S.D.

  • 1/16

    Nutlin-3a purchased from MedChemExpress. Usage Cited in: R Soc Open Sci. 2018 Aug 29;5(8):172376. [Abstract]

    Customer Validation
     HEKs are transfected with CRISPR/CAS9-gRNA for miR-143 or miR-145 for 48 h and then treated with nutlin-3a and Puromycin for another 24 h. The protein expression of NRAS and target genes in the PI3 K/ATK pathway is analysed by western blotting.

  • 1/16

    Nutlin-3a purchased from MedChemExpress. Usage Cited in: J Mater Chem B. 2017 Aug 7;5(29):5816-5834. [Abstract]

    Customer Validation
     Immunofluorescence staining of p53, caspase 3, and MDM2 proteins in HepG2 cells treated with microparticles loaded with nutlin-3a and β-CD-g-CS/pDNA 5 days after commencement of the treatment.

  • 1/16

    Nutlin-3a purchased from MedChemExpress. Usage Cited in: Eur J Med Chem. 2016 May 23:114:328-36. [Abstract]

    Customer Validation
     The effects of compounds A1, A7, A9 or Nutlin-3a in HCT116 cells by immunoprecipitation analysis

  • Nutlin-3a